Last reviewed · How we verify
NCT07160153: CANAA
Cannabis Abstinence and Neurocognitive Assessment in Adolescence
trial testing Neurocognitive assessment in Cannabis Dependence in 29 participants. Currently enrolling.
31 December 2028
Quick facts
| Lead sponsor | University Hospital Pilsen |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 29 |
| Start date | 3 December 2024 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 August 2029 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- Neurocognitive assessment
- Urine toxicological assessment
Conditions studied
- Cannabis Dependence — all drugs for Cannabis Dependence →
- Harmful Use — all drugs for Harmful Use →
- Cognitive Assessment — all drugs for Cognitive Assessment →
Sponsor
University Hospital Pilsen
Who can join
Adults 15 to 18, any sex, with Cannabis Dependence or Harmful Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cannabis Abstinence and Neurocognitive Assessment in Adolescence
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07160153
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Neurocognitive assessment
Trials testing the same drug.
- NCT04593069 — The COGCOV Study in ICU Patients · NA · completed
- NCT02592174 — Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of · NA · completed
Other recruiting trials for Cannabis Dependence
Currently open trials in the same condition.
- NCT07523633 — Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder · Phase 2 · recruiting
- NCT05219825 — Breathwork-assisted Treatment for Cannabis Use Disorder · NA · active not recruiting
Other University Hospital Pilsen trials
Trials by the same sponsor.
- NCT07285915 — The Role of Stress in Cardiac Arrest (Cortizol CPR) · NA · not yet recruiting
- NCT06634069 — Study SOLACE SEPSIS · Phase 2 · recruiting
- NCT06629701 — A Prospective Randomized Trial of External Vein Graft Support in Surgical Myocardial Revascularization · NA · enrolling by invitation
- NCT06923878 — Comparison of Skin Prick Testing, Extract-specific IgE Antibody Testing and Component Resolved Diagnosis in Diagnosing o · recruiting
- NCT04838418 — Transorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07160153 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Pilsen
- Last refreshed: 19 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07160153.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing